The Chinese government is reported to be "preparing" to share samples of avian influenza that were contracted by humans, according to a report in the International Herald Tribune. Recently, the World Health Organization reported that it had not received any samples from the country in over a year.
China escaped criticism for refusing to share samples of avian influenza found in humans with the World Health Organization, at a time when Indonesia was refusing to collaborate with the international agency, in a dispute over the intellectual property rights of discoveries made from Indonesian-supplied data (Marketletters passim). Despite China's reluctance to work with the WHO, Indonesia's stance was described as "unprecedented."
The China Daily newspaper, meanwhile, reported that the Health Ministry was in the process of arranging the delivery of H5N1 samples to the WHO. The government-controlled newspaper claimed that the Ministry "will send two recent samples of the virus and one from a Beijing resident who was infected in 2003."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze